Noticias de RNA_US

Noticias del mercado

Últimas noticias sobre RNA_US — 26 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RNA_US ✕ 26 resultados
26/06/2026 RNA_US — TradingKey ES ← EN
Valoración de Avidity Biosciences Inc (RNA): PE, PB y análisis de valor razonable

Avidity Biosciences Inc (RNA) Valuation: PE, PB & Fair Value Analysis

25/06/2026 RNA_US — TradingKey ES ← EN
Avidity Biosciences Inc (RNA) Salud financiera: análisis de rentabilidad y balance

Avidity Biosciences Inc (RNA) Financial Health: Profitability & Balance Sheet Analysis

22/06/2026 RNA_US — TradingKey ES ← EN
Confianza institucional de Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc (RNA) Institutional Confidence

20/06/2026 RNA_US — AD HOC NEWS
Avidity Biosciences Stock - Long-term strategy around RNA therapeutics

Avidity Biosciences se centra en conjugados anticuerpo-oligonucleótidos para músculos y neuromusculares raros.

19/06/2026 RNA_US — TradingKey ES ← EN
Evaluación de riesgos de Avidity Biosciences Inc (RNA): volatilidad, riesgo financiero y riesgo de inversión

Avidity Biosciences Inc (RNA) Risk Assessment: Volatility, Financial Risk & Investment Risk

19/06/2026 RNA_US — TradingKey ES ← EN
Pronóstico de ganancias de Avidity Biosciences Inc (RNA): EPS futuro y estimaciones de crecimiento de ingresos

Avidity Biosciences Inc (RNA) Earnings Forecast: Future EPS & Revenue Growth Estimates

18/06/2026 RNA_US — TradingKey ES ← EN
Análisis técnico de Avidity Biosciences Inc (RNA): soporte, resistencia, indicadores y medias móviles

Avidity Biosciences Inc (RNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

17/06/2026 RNA_US — TradingKey
Avidity Biosciences Inc (RNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
17/06/2026 RNA_US — TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings
17/06/2026 RNA_US — TradingKey
Avidity Biosciences Inc (RNA) Dividends & Stock Splits: Historical Payouts and Event Timeline
11/06/2026 RNA_US — Citeline News & Insights
Positive Del-Brax Biomarker Data Offers Early Support For Novartis’s Avidity Bet
29/05/2026 RNA_US — Finviz
RNA - Atrium Therapeutics Inc Stock Price and Quote
15/05/2026 RNA_US — Stock Titan
Avidity Biosciences (RNAM) Schedule 13G/A: RA Capital, Kolchinsky, Shah update ownership
15/05/2026 RNA_US — MarketBeat
Avidity Biosciences (RNA) Short Interest & Short Float | Updated May 2026 $RNA
09/05/2026 RNA_US — MEXC Exchange
RNAM Price Today: Avidity Biosciences, Inc. Stock Price, Quote & Chart | MEXC
29/04/2026 RNA_US — Barchart ES ← EN
Mercado de distrofia muscular facioescapulohumeral: la cartera farmacéutica impulsa una rápida expansión – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics

Facioscapulohumeral Muscular Dystrophy Market: Pharma Pipeline Fuels Rapid Expansion – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics

29/04/2026 RNA_US — openPR.com
Facioscapulohumeral Muscular Dystrophy Market: Pharma
29/04/2026 RNA_US — Barchart.com
Facioscapulohumeral Muscular Dystrophy Market: Pharma Pipeline Fuels Rapid Expansion – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics
26/04/2026 RNA_US — MSN ES ← EN
Avidity Biosciences informa datos de ensayos de tratamiento de DMD

Avidity Biosciences reports data from DMD treatment trials

26/04/2026 RNA_US — MSN ES ← EN
Avidity Biosciences informa datos de ensayos de tratamiento de DMD

Avidity Biosciences reports data from DMD treatment trials

Página 1 de 2

keyboard_arrow_up